News

FDA clears automated system for testing blood


 

ORTHO VISION™ Analyzer

Photo courtesy of

Ortho Clinical Diagnostics

The US Food and Drug Administration (FDA) has granted 510(k) clearance to the ORTHO VISIONTM Analyzer, a system that automates in vitro testing of human blood.

The system is now commercially available in the US and Puerto Rico.

The ORTHO VISION Analyzer automates test processing functions, including liquid pipetting, reagent handling, incubation, centrifugation, reaction grading, and interpretation and data management requirements using ID-MTS Gel Cards and digital image processing.

Tests that can be performed with the system include:

  • ABO/Rh/grouping
  • ABO/Rh confirmation
  • Antibody screen
  • Antibody identification
  • Selected cell panel
  • Rh phenotype (C,c,E,e)
  • Donor confirmation
  • Crossmatch (AHG)
  • Antigen typing
  • Serial dilutions for titration studies
  • DAT (polyspecific)
  • DAT (IGG)
  • Cord blood testing

The system can be used as a standalone instrument or interfaced to a laboratory information system.

The ORTHO VISION Analyzer was designed with secure monitoring technologies for safety checks and balances, and it allows transfusion medicine professionals to track steps in the immunohematology testing process.

Through Ortho Clinical Diagnostics’ proprietary Intellicheck Technology, the ORTHO VISION Analyzer verifies and documents diagnostic checks throughout the testing process, while e-Connectivity Technology provides 24/7 remote data tracking that monitors instrument performance while maximizing uptime. Laboratory personnel can log on anytime, anywhere to collaborate on interpreting results in real time.

“With the launch of the ORTHO VISION Analyzer, our goal is to help improve the safety of blood transfusions by reducing the lab’s reliance on manual methods,” said Robert Yates, chief operating officer of Ortho Clinical Diagnostics, the company developing the ORTHO VISION Analyzer.

A version of the ORTHO VISION Analyzer is already commercially available in Europe, Japan, Latin America, Canada, and Australia.

For more information on the system, visit the Ortho Clinical Diagnostics website.

Recommended Reading

FDA issues draft guidance on blood donation
MDedge Hematology and Oncology
FDA extends storage of platelets in plasma
MDedge Hematology and Oncology
FDA clears 7-day storage of platelets
MDedge Hematology and Oncology
Restrictive transfusion may be safe for AUGIB
MDedge Hematology and Oncology
PBM program improves outcomes, study shows
MDedge Hematology and Oncology
FDA clears test to detect bacteria in platelets
MDedge Hematology and Oncology
System can identify life-threatening bleeding
MDedge Hematology and Oncology
Drug on fast track to treat β-thalassemia
MDedge Hematology and Oncology
Whole blood better for cardiac surgery in young children
MDedge Hematology and Oncology
Enzyme could enable creation of universal blood type
MDedge Hematology and Oncology